Feldman Paul L
Reporting owner on Forms 3, 4 and 5, CIK 2050705.
Feldman Paul L reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AKTS · Aktis Oncology, Inc.CIK 2035832 | officer (Chief Scientific Officer) | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AKTS · Aktis Oncology, Inc.Common Stock | 2026-11-18 | M exercised | +55,035 | $1.9022 | 199,603 | Form 4 |
| AKTS · Aktis Oncology, Inc.Stock Option (Right to Buy), derivative | 2026-11-18 | M exercised | -55,035 | $0 | 10,678 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-468957 | Aktis Oncology, Inc. | 2026-11-19 |